Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Evaluation of a Remote Behavioural Stress Recovery Intervention for Myocardial Infarction Patients Younger Than Fifty-five (BRIM-55): A Feasibility Study (BRIM-55)

15 luglio 2026 aggiornato da: Erik Olsson, Uppsala University

The goal of this feasibility study is to learn if the randomised controlled trial evaluating the Remote-delivery Balance in Everyday Life (rBEL) programme for adults younger than 55 years who have experienced a myocardial infarction (MI), is feasible.

The objective is to examine the feasibility of the rBEL programme and the associated study procedures before a controlled evaluation of the programme. This is an uncontrolled, single-arm, pre-post treatment designed study.

Participants of the target population will take part of the six session over 13 week programme. Feasibility will be evaluated against predefined feasibility criteria regarding study procedures and programme acceptability.

Panoramica dello studio

Descrizione dettagliata

BACKGROUND Even though there have been major improvements in medical treatments resulting in considerably lower mortality rates, cardiovascular diseases (CVDs) remain the leading cause of death and the main cause of loss of disability-adjusted life-years worldwide. Myocardial infarction (MI) is the most common of the serious CVDs. While the total number of MIs has decreased during the last decades, the proportion of young patients hospitalized with MI has increased.

Cardiac distress (CD) summaries the psychological impacts of a cardiac event and expands on the general "psychological distress" concept (i.e. symptoms of depression and anxiety). Cardiac distress is common after an MI. For young persons, having an MI is particularly stressful and the prevalence of anxiety and depression is more than double compared to that of older patients.

Conventional stress management intervention programs are based on a "reactivity paradigm", with techniques used to reduce, avoid, or change the interpretation of the stressors and/or stress responses associated with distress. An alternative, contrasting strategy is to address recovery processes. To the best of our knowledge, the intervention program Balance in Everyday Life (BEL), based on cognitive behavioural principles, has the best empirical support.

Guidelines for cardiac rehabilitation recommend screening of psychosocial aspects but interventions in this area are very rare in clinical practice.

METHOD Aim The aims are to assess feasibility and acceptability of the iBEL program for post-myocardial infarction survivors aged below 55 years reported ongoing CD, and the study procedures of the later evaluation study.

Research Questions

  1. How feasible is the study procedures of the planned evaluation study in terms of recruitment, retention and adherence rates?
  2. To what extent is the iBEL program perceived as acceptable to young post-MI survivors, in terms of its content, delivery method and relevancy?

Design An uncontrolled, single-arm, pre-post treatment design.

Participants Thirty participants of the target population will be included. Exclusion criteria: (i) not being able to read, write or speak Swedish, (ii) being able to use the digital device necessary for participation and (iii) early retirement or disability pension at the time of the MI.

Procedure Participants will be recruited via a register extraction from SWEDEHEART of all persons having an MI before the age of 55 one year before intervention start. Preliminary eligible participants will be sent an invitation letter primarily via a digital post-box with a description of the study and an option to register interest for the study. To qualify as participants with CD, they must state they have at least experienced moderate distress as a consequence of their MI which impairs day-to-day recovery, and they believe psychological support will benefit them. They are then asked to provide written consent.

The Program The program consists of 6 sessions spread out over 13 weeks. Each session includes a video-call meeting online, via the platform Zoom, with a therapist. The therapists are healthcare workers (clinical social workers-LCSW, MSW specialized in psychotherapy, nurses psychiatric/mental health nurse practitioners- PMHNPs, occupational therapists with mental health specialization) with training in clinical conversations or students recruited from the final semesters of the university programs for psychologists or physiotherapists with basic training in clinical conversations. They will be trained in the rBEL program and receive supervision by a senior therapist. Before each data collection time-point, participants will be prompted and, if necessary, reminded to report via SMS and/or e-mail, based on their preference, and thereafter, if needed, via telephone.

In addition to this meeting with the therapist there is psychoeducational material on a website (www.brim55.se) and a printed booklet for exercise notations.

Data analysis The feasibility results will be evaluated against pre-specified progression criteria. The sample size (N=30) is based on a rule-of-thumb for feasibility studies and is judged to be enough for detecting feasibility concerns.

Tipo di studio

Interventistico

Iscrizione (Stimato)

30

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Luoghi di studio

      • Uppsala, Svezia, 752 37
        • Uppsala University
        • Contatto:

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto

Accetta volontari sani

No

Descrizione

Inclusion criteria:

  • Myocardial infarction (MI) before age 55 years
  • MI within one year prior to randomization
  • Report of subjective cardiac distress in the initial interview

Exclusion criteria:

  • Serious conditions hindering participation (e.g., active substance misuse, severe mental illness)
  • Insufficient Swedish proficiency for study procedures,
  • Disability pension or early retirement at the time of MI

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: N / A
  • Modello interventistico: Assegnazione di gruppo singolo
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Remote-delivery Balance in Everyday Life (rBEL) intervention group
Participants randomized to this arm will receive the Remote-delivery Balance in Everyday Life (rBEL) program, a therapist-supported behavioral stress recovery intervention delivered over 12 weeks. The program includes six individual online sessions, a printed workbook containing exercises and self-monitoring materials, and access to online video resources. The intervention is designed to promote recovery behaviors, improve stress regulation, and reduce cardiac distress following myocardial infarction.
The Remote-delivery Balance in Everyday Life (rBEL) program is a 13-week therapist-supported behavioral stress recovery intervention for adults younger than 55 years who have experienced a myocardial infarction and report cardiac distress. The program includes six individual online sessions delivered by a therapist, a printed exercise workbook, and online video materials. The content focuses on recovery behaviors, relaxation training, self-monitoring, use of recovery strategies in daily life and work settings, and management of heart-related worry and anxiety.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Recruitment
Lasso di tempo: Six weeks from when the invitation letter was sent out

The pre-specified progression criteria are formulated as Green=Go ahead, Yellow=Amend, Red=Revise.

Green: ≥8% of the invited population starting intervention. Yellow: <8% and ≥6%. Red: <6%.

Six weeks from when the invitation letter was sent out
Acceptability
Lasso di tempo: Four weeks from the screening interview

The pre-specified progression criteria are formulated as Green=Go ahead, Yellow=Amend, Red=Revise.

Green: ≥75% of eligible participants consent. Yellow: <75% and ≥60%. Red: <60%.

Four weeks from the screening interview
Participant adherence
Lasso di tempo: From start of intervention to 12 weeks later.

The pre-specified progression criteria are formulated as Green=Go ahead, Yellow=Amend, Red=Revise.

Green: ≥70% of the participants completing a minimum of 4 sessions with the therapist.

Yellow:<70% and ≥60%. Red: <60%

From start of intervention to 12 weeks later.
Retention
Lasso di tempo: From the end of the intervention to two weeks later.

The pre-specified progression criteria are formulated as Green=Go ahead, Yellow=Amend, Red=Revise.

Green: ≥90% complete data on the CDI, post-treatment. Yellow: <90% and ≥75%. Red: <75%.

From the end of the intervention to two weeks later.
Adverse events
Lasso di tempo: From intervention start to four weeks after intervention end.

The pre-specified progression criteria are formulated as Green=Go ahead, Yellow=Amend, Red=Revise.

Green: no inconveniences or adverse events linked to study participation reported.

Yellow: ≤ 2 reports of inconveniences (comparable to max 2 days of increased fatigue, stress or worry).

Red: any adverse event or more than 3 inconveniences reported linked to study participation

From intervention start to four weeks after intervention end.
Program credibility
Lasso di tempo: Rating is done after first intervention session (first week of intervention). A two week submission period is allowed.

The pre-specified progression criteria are formulated as Green=Go ahead, Yellow=Amend, Red=Revise. The credibility subscale of the Credibility and Expectancy Questionnaire has a max score of 27. A higher score means more credibility.

Green: ≥75% of participants rate the credibility subscale of CEQ ≥ 7. Yellow: ≥75% rate it < 7 and ≥ 5. Red: >25% rate it < 5.

Rating is done after first intervention session (first week of intervention). A two week submission period is allowed.
Program satisfaction
Lasso di tempo: From the end of the intervention to two weeks later.

The pre-specified progression criteria are formulated as Green=Go ahead, Yellow=Amend, Red=Revise. The Client Satisfaction Questionnaire 8 items version (CSQ-8) has a max score of 32 where a higher score means more satisfaction.

Green: ≥ 75% of participants score ≥26 on the CSQ-8. Yellow: ≥ 75% rate it ≥24. Red: > 25% rate it <24.

From the end of the intervention to two weeks later.

Altre misure di risultato

Misura del risultato
Misura Descrizione
Lasso di tempo
Cardiac distress
Lasso di tempo: Mid intervention (CDI short form): After session 3 (2 week submission period) After intervention: From the end of the intervention to two weeks later.
Cardiac Distress Inventory (CDI)
Mid intervention (CDI short form): After session 3 (2 week submission period) After intervention: From the end of the intervention to two weeks later.
Recovery Experience
Lasso di tempo: Mid intervention: After session 3 (2 week submission time frame). After intervention: From the end of the intervention to two weeks later.
The Recovery Experience Questionnaire (REQ) has a max score of 80 where a higher score means more recovery.
Mid intervention: After session 3 (2 week submission time frame). After intervention: From the end of the intervention to two weeks later.
Health-related quality of life
Lasso di tempo: From the end of the intervention to two weeks later.
The HeartQoL instrument has a max score of 42 where a higher score means better quality of life.
From the end of the intervention to two weeks later.
Depression
Lasso di tempo: From the end of the intervention to two weeks later.
The Patient Health Questionnaire, 9 items (PHQ-9) has a max score of 27. A higher score means more depressed.
From the end of the intervention to two weeks later.
Anxiety
Lasso di tempo: From the end of the intervention to two weeks later.
The instrument General Anxiety Disorder, 7 items version (GAD-7) has a max score of 21. A higher score means more anxiety.
From the end of the intervention to two weeks later.
Working ability
Lasso di tempo: From the end of the intervention to two weeks later.
Work Ability Index has a max score of 49 where a higher score means better working ability.
From the end of the intervention to two weeks later.
Healthcare costs
Lasso di tempo: From the end of the intervention to two weeks later.
The instrument Treatment Inventory of Costs in Patients with psychiatric disorders, Midi version (TIC-P Midi) counts visits in health care. The more visits the higher the costs. Visits to specialists and hospital stays means higher costs than outpatient visits.
From the end of the intervention to two weeks later.

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Investigatore principale: Erik Olsson MG Olsson, Professor, Uppsala University

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

24 agosto 2026

Completamento primario (Stimato)

31 gennaio 2027

Completamento dello studio (Stimato)

30 giugno 2027

Date di iscrizione allo studio

Primo inviato

2 luglio 2026

Primo inviato che soddisfa i criteri di controllo qualità

15 luglio 2026

Primo Inserito (Effettivo)

16 luglio 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

16 luglio 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

15 luglio 2026

Ultimo verificato

1 luglio 2026

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Descrizione del piano IPD

Due to the European data protection law, this will not be allowed without a special ethical approval.

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi